Unlike many prognostic biomarkers based on tumor characteristics that cannot be modified, VSR is a modifiable risk factor through changes in diet and exercise as well as weight management drugs such as glucagon-like peptide-1 (GLP-1) receptor agonists. The gene discussed is GLP1R; the disease is neoplasm.